240
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Nocturnal non-invasive ventilation for cardio-respiratory disorders in adults

&
Pages 615-629 | Published online: 09 Jan 2014

References

  • Henke KG, Badr MS, Skatrud JB, Dempsey JA. Load compensation and respiratory muscle function during sleep. J. Appl. Physiol. 72(4), 1221–1234 (1992).
  • Dempsey JA, Smith CA, Harms CA, Chow C, Saupe KW. Sleep-induced breathing instability. University of Wisconsin-Madison S leep and respiration Research Group. Sleep 19(3), 236–247 (1996).
  • Smith PE, Edwards PH, Calverley PM. Ventilation and breathing pattern during sleep in Duchenne muscular dystrophy. Chest 96(6), 1346–1351 (1989).
  • Takasugi T, Ishihara T, Kawamura J et al. Respiratory disorders during sleep in Duchenne muscular dystrophy. Nihon Kyobu Shikkan Gakkai Zasshi 33(8), 821–828 (1995).
  • Veale D, Cooper BG, Gilmartin JJ, Walls TJ, Griffith CJ, Gibson GJ. Breathing pattern awake and asleep in patients with myotonic dystrophy. Eur. Respir. J. 8(5), 815–818 (1995).
  • Ono S, Takahashi K, Jinnai K et al. Loss of catecholaminergic neurons in the medullary reticular formation in myotonic dystrophy. Neurology 51(4), 1121–1124 (1998).
  • Annane D, Quera-Salva MA, Lofaso F et al. Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular disease. Eur. Respir. J. 13(1), 157–162 (1999).
  • Barbe F, Quera-Salva MA, de Lattre J, Gajdos P, Agusti AG. Long-term effects of nasal intermittent positive-pressure ventilation on pulmonary function and sleep architecture in patients with neuromuscular diseases. Chest 110(5), 1179–1183 (1996).
  • Mayer P, Dematteis M, Pepin JL et al. Peripheral neuropathy in sleep apnea. A tissue marker of the severity of nocturnal desaturation. Am. J. Respir. Crit. Care Med. 159(1), 213–219 (1999).
  • White DP, Douglas NJ, Pickett CK, Zwillich CW, Weil JV. Sleep deprivation and the control of ventilation. Am. Rev. Respir. Dis. 128(6), 984–986 (1983).
  • Cropp A, DiMarco AF. Effects of intermittent negative pressure ventilation on respiratory muscle function in patients with severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 135(5), 1056–1061 (1987).
  • Gutierrez M, Beroiza T, Contreras G et al. Weekly cuirass ventilation improves blood gases and inspiratory muscle strength in patients with chronic air-flow limitation and hypercarbia. Am. Rev. Respir. Dis. 138(3), 617–623 (1988).
  • Scano G, Gigliotti F, Duranti R, Spinelli A, Gorini M, Schiavina M. Changes in ventilatory muscle function with negative pressure ventilation in patients with severe COPD. Chest 97(2), 322–327 (1990).
  • Renston JP, DiMarco AF, Supinski GS. Respiratory muscle rest using nasal BiPAP ventilation in patients with stable severe COPD. Chest 105(4), 1053–1060 (1994).
  • Heckmatt JZ, Loh L, Dubowitz V. Night-time nasal ventilation in neuromuscular disease. Lancet 335(8689), 579–582 (1990).
  • Shneerson JM. The changing role of mechanical ventilation in COPD. Eur. Respir. J. 9(3), 393–398 (1996).
  • Priou P, Hamel JF, Person C et al. Long-term outcome of noninvasive positive pressure ventilation for obesity hypoventilation syndrome. Chest 138(1), 84–90 (2010).
  • Schönhofer B, Geibel M, Sonneborn M, Haidl P, Köhler D. Daytime mechanical ventilation in chronic respiratory insufficiency. Eur. Respir. J. 10(12), 2840–2846 (1997).
  • Cheng SL, Chan VL, Chu CM. Compliance with home non-invasive ventilation. Respirology 17(4), 735–736 (2012).
  • Restrick LJ, Fox NC, Braid G, Ward EM, Paul EA, Wedzicha JA. Comparison of nasal pressure support ventilation with nasal intermittent positive pressure ventilation in patients with nocturnal hypoventilation. Eur. Respir. J. 6(3), 364–370 (1993).
  • Chadda K, Clair B, Orlikowski D, Macadoux G, Raphael JC, Lofaso F. Pressure support versus assisted controlled noninvasive ventilation in neuromuscular disease. Neurocrit. Care 1(14), 429–434 (2004).
  • Muñoz X, Crespo A, Marti S, Torres F, Ferrer J, Morell F. Comparative study of two different modes of noninvasive home mechanical ventilation in chronic respiratory failure. Respir. Med. 100(4), 673–681 (2006).
  • Windisch W, Storre JH, Sorichter S, Virchow JC Jr. Comparison of volume- and pressure-limited NPPV at night: a prospective randomized cross-over trial. Respir. Med. 99(1), 52–59 (2005).
  • Vitacca M, Rubini F, Foglio K, Scalvini S, Nava S, Ambrosino N. Non-invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients. Intensive Care Med. 19(8), 450–455 (1993).
  • Hess DR. The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature. Respir. Care 49(7), 810–829 (2004).
  • Pinto A, Almeida JP, Pinto S, Pereira J, Oliveira AG, de Carvalho M. Home telemonitoring of non-invasive ventilation decreases healthcare utilization in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 81(11), 1238–1242 (2010).
  • Hess DR. Noninvasive ventilation in neuromuscular disease: equipment and application. Respir. Care 51(8), 896–911 (2006).
  • Berry RB, Chediak A, Brown LK et al. Best clinical practices for the sleep center adjustment of noninvasive positive pressure ventilation (NPPV) in stable chronic alveolar hypoventilation syndromes. J. Clin. Sleep Med. 6(5), 491–509 (2010).
  • Hess DR. Patient-ventilator interaction during noninvasive ventilation. Respir. Care 56(20), 153–165 (2011).
  • Piper AJ, Grunstein RR. Obesity hypoventilation syndrome: mechanisms and management. Am. J. Respir. Crit. Care Med. 183(3), 292–298 (2011).
  • Dellweg D, Hochrainer D, Klauke M, Kerl J, Eiger G, Kohler D. Determinants of skin contact pressure formation during non-invasive ventilation. J. Biomech. 43(4), 652–657 (2010).
  • Carron M, Freo U, BaHammam AS et al. Complications of non-invasive ventilation techniques: a comprehensive qualitative review of randomized trials. Br. J. Anaesth. 110(6), 896–914 (2013).
  • Nava S, Navalesi P, Gregoretti C. Interfaces and humidification for noninvasive mechanical ventilation. Respir. Care 54(1), 71–84 (2009).
  • Sferrazza Papa GF, Di Marco F, Akoumianaki E, Brochard L. Recent advances in interfaces for non-invasive ventilation: from bench studies to practical issues. Minerva Anestesiol. 78(10), 1146–1153 (2012).
  • Mador MJ, Krauza M, Pervez A, Pierce D, Braun M. Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 128(4), 2151–2158 (2005).
  • Leung P, Jubran A, Tobin MJ. Comparison of assisted ventilator modes on triggering, patient effort, and dyspnea. Am. J. Respir. Crit. Care Med. 155(6), 1940–1948 (1997).
  • Raphael JC, Chevret S, Chastang C, Bouvet F. Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French multicentre cooperative group on home mechanical ventilation assistance in Duchenne de Boulogne muscular dystrophy. Lancet 343(8913), 1600–1604 (1994).
  • Carrillo A, Ferrer M, Gonzalez-Diaz G et al. Noninvasive ventilation in acute hypercapnic respiratory failure caused by obesity hypoventilation syndrome and chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 186(12), 1279–1285 (2012).
  • Javaheri S, Parker TJ, Wexler L et al. Occult sleep-disordered breathing in stable congestive heart failure. Ann. Intern. Med. 122(7), 487–492 (1995).
  • Javaheri S, Parker TJ, Liming JD et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 97(21), 2154–2159 (1998).
  • Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int. J. Cardiol. 106(1), 21–28 (2006).
  • Oldenburg O, Lamp B, Faber L, Teschler H, Horstkotte D, Topfer V. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur. J. Heart Fail. 9(3), 251–257 (2007).
  • MacDonald M, Fang J, Pittman SD, White DP, Malhotra A. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J. Clin. Sleep Med. 4(1), 38–42 (2008).
  • Hagenah G, Beil D. Prevalence of Cheyne-Stokes respiration in modern treated congestive heart failure. Sleep Breath. 13(2), 181–185 (2009).
  • Bitter T, Faber L, Hering D, Langer C, Horstkotte D, Oldenburg O. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur. J. Heart Fail. 11(6), 602–608 (2009).
  • Hanly P, Zuberi N, Gray R. Pathogenesis of Cheyne-Stokes respiration in patients with congestive heart failure. Relationship to arterial PCO2. Chest 104(4), 1079–1084 (1993).
  • Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T. Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am. J. Respir. Crit. Care Med. 159(5 Pt 1), 1490–1498 (1999).
  • Glogowska M, Widdicombe JG. The role of vagal reflexes in experimental lung oedema, bronchoconstriction and inhalation of halothane. Respir. Physiol. 18(1), 116–128 (1973).
  • Fanfulla F, Mortara A, Maestri R et al. The development of hyperventilation in patients with chronic heart failure and Cheyne-Stokes respiration: a possible role of chronic hypoxia. Chest 114(4), 1083–1090 (1998).
  • Padeletti M, Green P, Mooney AM, Basner RC, Mancini DM. Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med. 10(3), 353–360 (2009).
  • Lanfranchi PA, Braghiroli A, Bosimini E et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99(11), 1435–1440 (1999).
  • Javaheri S, Shukla R, Zeigler H, Wexler L. Central sleep apnea, right ventricular dysfunction, and low diastolic blood pressure are predictors of mortality in systolic heart failure. J. Am. Coll. Cardiol. 49(20), 2028–2034 (2007).
  • Wang H, Parker JD, Newton GE et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J. Am. Coll. Cardiol. 49(15), 1625–1631 (2007).
  • Jilek C, Krenn M, Sebah D et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur. J. Heart Fail. 13(1), 68–75 (2011).
  • Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates CJ. Continuous positive airway pressure for obstructive sleep apnea in adults. Cochrane Database Syst. Rev. (3), CD001106 (2006).
  • Solomon SD, Anavekar N, Skali H et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112(24), 3738–3744 (2005).
  • Malone S, Liu PP, Holloway R, Rutherford R, Xie A, Bradley TD. Obstructive sleep apnea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet 338(8781), 1480–1484 (1991).
  • Kaneko Y, Floras JS, Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N. Engl. J. Med. 348(13), 1233–1241 (2003).
  • Mansfield DR, Gollogly NC, Kaye DM, Richardson M, Bergin P, Naughton MT. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am. J. Respir. Crit. Care Med. 169(3), 361–366 (2004).
  • Smith LA, Vennelle M, Gardner RS et al. Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnea: a randomized placebo-controlled trial. Eur. Heart J. 28(10), 1221–1227 (2007).
  • Bradley TD, Logan AG, Kimoff RJ et al. Continuous positive airway pressure for central sleep apnea and heart failure. N. Engl. J. Med. 353(19), 2025–2033 (2005).
  • Arzt M, Floras JS, Logan AG et al. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115(25), 3173–3180 (2007).
  • Aurora RN, Chowdhuri S, Ramar K et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep 35(1), 17–40 (2012).
  • Philip-Joët FF, Paganelli FF, Dutau HL, Saadjian AY. Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure. Respiration 66(2), 136–143 (1999).
  • Yoshida M, Kadokami T, Momii H et al. Enhancement of cardiac performance by bilevel positive airway pressure ventilation in heart failure. J. Card. Fail. 18(12), 912–918 (2012).
  • Willson GN, Wilcox I, Piper AJ, Flynn WE, Grunstein RR, Sullivan CE. Treatment of central sleep apnoea in congestive heart failure with nasal ventilation. Thorax 53( Suppl. 53), S41–S46 (1998).
  • Willson GN, Wilcox I, Piper AJ et al. Noninvasive pressure preset ventilation for the treatment of Cheyne-Stokes respiration during sleep. Eur. Respir. J. 17(6), 1250–1257 (2001).
  • Köhnlein T, Welte T, Tan LB, Elliott MW. Assisted ventilation for heart failure patients with Cheyne-Stokes respiration. Eur. Respir. J. 20(4), 934–941 (2002).
  • Kasai T, Narui K, Dohi T et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with cheyne-stokes respiration and central sleep apnea. Circ. J. 69(8), 913–921 (2005).
  • Dohi T, Kasai T, Narui K et al. Bi-level positive airway pressure ventilation for treating heart failure with central sleep apnea that is unresponsive to continuous positive airway pressure. Circ. J. 72(7), 1100–1105 (2008).
  • Johnson KG, Johnson DC. Bilevel positive airway pressure worsens central apneas during sleep. Chest 128(4), 2141–2150 (2005).
  • Teschler H, Döhring J, Wang YM, Berthon-Jones M. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am. J. Respir. Crit. Care Med. 164(4), 614–619 (2001).
  • Philippe C, Stoïca-Herman M, Drouot X et al. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92(3), 337–342 (2006).
  • Pepperell JC, Maskell NA, Jones DR et al. A randomized controlled trial of adaptive ventilation for Cheyne-Stokes breathing in heart failure. Am. J. Respir. Crit. Care Med. 168(9), 1109–1114 (2003).
  • Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servoventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest 142(5), 1211–1221 (2012).
  • Kasai T, Usui Y, Yoshioka T et al. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ. Heart Fail 3(1), 140–148 (2010).
  • Takama N, Kurabayashi M. Effect of adaptive servo-ventilation on 1-year prognosis in heart failure patients. Circ. J. 76(3), 661–667 (2012).
  • Bitter T, Westerheide N, Faber L et al. Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur. Respir. J. 36(2), 385–392 (2010).
  • Yoshihisa A, Suzuki S, Yamaki T et al. Impact of adaptive servo-ventilation on cardiovascular function and prognosis in heart failure patients with preserved left ventricular ejection fraction and sleep-disordered breathing. Eur. J. Heart Fail. 15(5), 543–550 (2013).
  • Teller, ES, Yuen G, Reyes-Vidal C et al. Adaptive servo-ventilation for treatment of Cheyne-Stokes breathing in acutely decompensated heart failure. Am. J. Respir. Crit. Care Med. 179, A5337 (2009).
  • Raherison C, Girodet PO. Epidemiology of COPD. Eur. Respir. Rev. 18(114), 213–221 (2009).
  • Decramer M. Hyperinflation and respiratory muscle interaction. Eur. Respir. J. 10(4), 934–941 (1997).
  • Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 5(4), 549–555 (2008).
  • Fletcher EC, Costarangos C, Miller T. The rate of fall of arterial oxyhemoglobin saturation in obstructive sleep apnea. Chest 96(4), 717–722 (1989).
  • McNicholas WT, Fitzgerald MX. Nocturnal deaths among patients with chronic bronchitis and emphysema. Br. Med. J. 289(6449), 878 (1984).
  • Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am. J. Respir. Crit. Care Med. 182(3), 325–331 (2010).
  • Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N. Engl. J. Med. 337(25), 1799–1806 (1997).
  • Wijkstra PPJ, Lacasse Y, Guyatt GH, Goldstein R, Struik F. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. (2), CD002878 (2002).
  • Wijkstra PJ, Lacasse Y, Guyatt GH et al. A meta-analysis of nocturnal noninvasive positive pressure ventilation in patients with stable COPD. Chest 124(1), 337–343 (2003).
  • Strumpf DA, Millman RP, Carlisle CC et al. Nocturnal positive-pressure ventilation via nasal mask in patients with severe chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 144(6), 1234–1239 (1991).
  • Gay PC, Hubmayr RD, Stroetz RW. Efficacy of nocturnal nasal ventilation in stable, severe chronic obstructive pulmonary disease during a 3-month controlled trial. Mayo. Clin. Proc. 71(6), 533–542 (1996).
  • Meecham Jones D, Paul EA, Jones PW, Wedzicha JA. Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD. Am. J. Respir. Crit. Care Med. 152(2), 538–544 (1995).
  • Casanova C, Celli BR, Tost L et al. Long-term controlled trial of nocturnal nasal positive pressure ventilation in patients with severe COPD. Chest 118(6), 1582–1590 (2000).
  • Clini E, Sturani C, Rossi A et al. The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients. Eur. Respir. J. 20(3), 529–538 (2002).
  • McEvoy RD, Pierce RJ, Hillman D et al. Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial. Thorax 64(7), 561–566 (2009).
  • Köhnlein T, Schönheit-Kenn U, Winterkamp S, Welte T, Kenn K. Noninvasive ventilation in pulmonary rehabilitation of COPD patients. Respir. Med. 103(9), 1329–1336 (2009).
  • Garrod R, Mikelsons C, Paul EA, Wedzicha JA. Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162(4 Pt 1), 1335–1341 (2000).
  • Duiverman ML, Wempe JB, Bladder G et al. Nocturnal non-invasive ventilation in addition to rehabilitation in hypercapnic patients with COPD. Thorax 63(12), 1052–1057 (2008).
  • Duiverman ML, Wempe JB, Bladder G et al. Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respir. Res. 12, 112 (2011).
  • Windisch W, Dreher M, Storre JH, Sorichter S. Nocturnal non-invasive positive pressure ventilation: physiological effects on spontaneous breathing. Respir. Physiol. Neurobiol. 150(2–3), 251–260 (2006).
  • Dreher M, Storre JH, Schmoor C, Windisch W. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax 65(4), 303–308 (2010).
  • Lukácsovits J, Carlucci A, Hill N et al. Physiological changes during low- and high-intensity noninvasive ventilation. Eur. Respir. J. 39(4), 869–875 (2012).
  • Kolodziej MA, Jensen L, Rowe B, Sin D. Systematic review of noninvasive positive pressure ventilation in severe stable COPD. Eur. Respir. J. 30(2), 293–306 (2007).
  • Shi JX, Xu J, Sun WK, Su X, Zhang Y, Shi Y. Effect of noninvasive, positive pressure ventilation on patients with severe, stable chronic obstructive pulmonary disease: a meta-analysis. Chin. Med. J. 126(1), 140–146 (2013).
  • Berg G, Delaive K, Manfreda J, Walld R, Kryger MH. The use of health-care resources in obesity-hypoventilation syndrome. Chest 120(2), 377–383 (2001).
  • Nowbar S, Burkart KM, Gonzales R et al. Obesity-associated hypoventilation in hospitalized patients: prevalence, effects, and outcome. Am. J. Med. 116(1), 1–7 (2004).
  • Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir. Care 55(10), 1347–1362 (2010).
  • Rapoport DM, Sorkin B, Garay SM, Goldring RM. Reversal of the “Pickwickian syndrome” by long-term use of nocturnal nasal-airway pressure. N. Engl. J. Med. 307(15), 931–933 (1982).
  • Sullivan CE, Berthon-Jones M, Issa FG. Remission of severe obesity-hypoventilation syndrome after short-term treatment during sleep with nasal continuous positive airway pressure. Am. Rev. Respir. Dis. 128(1), 177–181 (1983).
  • Banerjee D, Yee BJ, Piper AJ, Zwillich CW, Grunstein RR. Obesity hypoventilation syndrome: hypoxemia during continuous positive airway pressure. Chest 131(6), 1678–1684 (2007).
  • Pérez de Llano LA, Golpe R, Piquer MO et al. Clinical heterogeneity among patients with obesity hypoventilation syndrome: therapeutic implications. Respiration 75(1), 34–39 (2008).
  • Piper AJ, Wang D, Yee BJ, Barnes DJ, Grunstein RR. Randomised trial of CPAP vs bilevel support in the treatment of obesity hypoventilation syndrome without severe nocturnal desaturation. Thorax 63(5), 395–401 (2008).
  • Budweiser S, Riedl SG, Jörres RA, Heinemann F, Pfeifer M. Mortality and prognostic factors in patients with obesity-hypoventilation syndrome undergoing noninvasive ventilation. J. Intern. Med. 261(4), 375–383 (2007).
  • Storre JH, Seuthe B, Fiechter R et al. Average volume-assured pressure support in obesity hypoventilation: A randomized crossover trial. Chest 130(3), 815–821 (2006).
  • Murphy PB, Davidson C, Hind MD et al. Volume targeted versus pressure support non-invasive ventilation in patients with super obesity and chronic respiratory failure: a randomised controlled trial. Thorax 67(8), 727–734 (2012).
  • Contal O, Adler D, Borel JC et al. Impact of different backup respiratory rates on the efficacy of noninvasive positive pressure ventilation in obesity hypoventilation syndrome: a randomized trial. Chest 143(1), 37–46 (2013).
  • Flenley DC. Sleep in chronic obstructive lung disease. Clin. Chest Med. 6(4), 651–661 (1985).
  • Owens RL, Malhotra A. Sleep-disordered breathing and COPD: the overlap syndrome. Respir. Care 55(10), 1333–1344 (2010).
  • Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am. J. Respir. Crit. Care Med. 151(1), 82–86 (1995).
  • Sanders MH, Newman AB, Haggerty CL et al. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am. J. Respir. Crit. Care. Med. 167(1), 7–14 (2003).
  • Weitzenblum E, Krieger J, Apprill M et al. Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am. Rev. Respir. Dis. 138(2), 345–349 (1988).
  • Hawryłkiewicz I, Sliwiński P, Górecka D, Pływaczewski R, Zieliłski J. Pulmonary haemodynamics in patients with OSAS or an overlap syndrome. Monaldi Arch. Chest Dis. 61(3), 148–152 (2004).
  • Bradley TD, Rutherford R, Grossman RF et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am. Rev. Respir. Dis. 131(6), 835–839 (1985).
  • Lavie P, Herer P, Lavie L. Mortality risk factors in sleep apnoea: a matched case-control study. J. Sleep Res. 16(1), 128–134 (2007).
  • Mermigkis C, Kopanakis A, Foldvary-Schaefer N et al. Health-related quality of life in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease (overlap syndrome). Int. J. Clin. Pract. 61(2), 207–211 (2007.
  • Sampol G, Sagalés MT, Roca A, de la Calzada MD, Bofill JM, Morell F. Nasal continuous positive airway pressure with supplemental oxygen in coexistent sleep apnoea-hypopnoea syndrome and severe chronic obstructive pulmonary disease. Eur. Respir. J. 9(1), 111–116 (1996).
  • Mansfield D, Naughton MT. Effects of continuous positive airway pressure on lung function in patients with chronic obstructive pulmonary disease and sleep disordered breathing. Respirology 4(4), 365–370 (1999).
  • de Miguel J, Cabello J, Sánchez-Alarcos JM, Alvarez-Sala R, Espinós D, Alvarez-Sala JL. Long-term effects of treatment with nasal continuous positive airway pressure on lung function in patients with overlap syndrome. Sleep Breath. 6(1), 3–10 (2002).
  • Toraldo DM, De Nuccio F, Nicolardi G. Fixed-pressure nCPAP in patients with obstructive sleep apnea (OSA) syndrome and chronic obstructive pulmonary disease (COPD): a 24-month follow-up study. Sleep Breath. 14(2), 115–123 (2010).
  • O'Brien A, Whitman K. Lack of benefit of continuous positive airway pressure on lung function in patients with overlap syndrome. Lung 183(6), 389–404 (2005).
  • Kouns A, Phillips B. New developments in the management of chronic obstructive pulmonary disease and the overlap syndrome. Curr. Treat. Options Neurol. 13(5), 488–495 (2011).
  • Machado MC, Vollmer WM, Togeiro SM et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur. Respir. J. 35(1), 132–137 (2010).
  • Ratjen F, Döring G. Cystic fibrosis. Lancet 361(9358), 681–689 (2003).
  • Fauroux B. Noninvasive ventilation in cystic fibrosis. Expert Rev. Respir. Med. 4(1), 39–46 (2010).
  • Moran F, Bradley JM, Piper AJ. Non-invasive ventilation for cystic fibrosis. Cochrane Database Syst. Rev. (4), CD002769 (2013).
  • Gozal D. Nocturnal ventilatory support in patients with cystic fibrosis: comparison with supplemental oxygen. Eur. Respir. J. 10(9), 1999–2003 (1997).
  • Milross MA, Piper AJ, Norman M et al. Low-flow oxygen and bilevel ventilatory support: effects on ventilation during sleep in cystic fibrosis. Am. J. Respir. Crit. Care Med. 163(1), 129–134 (2001).
  • Young AC, Wilson JW, Kotsimbos TC, Naughton MT. Randomised placebo controlled trial of non-invasive ventilation for hypercapnia in cystic fibrosis. Thorax 63(1), 72–77 (2008).
  • Madden BP, Kariyawasam H, Siddiqi AJ, Machin A, Pryor JA, Hodson ME. Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure. Eur. Respir. J. 19(2), 310–313 (2002).
  • Segall D. Noninvasive nasal mask-assisted ventilation in respiratory failure of Duchenne muscular dystrophy. Chest 93(6), 1298–1300 (1988).
  • Miller RG, Jackson CE, Kasarskis EJ et al. Practice Parameter update: The care of the patient with amyotrophic lateral scleroris: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 73(15), 1218–1226 (2009).
  • Annane D, Orlikowski D, Chevret S, Chevrolet JC, Raphaël JC. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst. Rev. (4), CD001941 (2007).
  • Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomized controlled trial. Lancet Neurol. 5(2), 140–147 (2006).
  • Pinto AC, Evangelista T, Carvalho M, Alves MA, Sales Luis ML. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: survival rates in a controlled trial. J. Neurol. Sci. 129(Suppl.), 19–26 (1995).
  • Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 60(12), 1019–1024 (2005).
  • Atkeson AD, Roy Choudhury A, Harrington-Moroney G, Shah B, Mitsumoto H, Basner RC. Patient-ventilator asynchrony with nocturnal noninvasive ventilation in ALS. Neurology 77(6), 549–555 (2011).
  • Atkeson AD, Persaud R, Roy Choudhury A, Harrington-Moroney G, Mitsumoto H, Basner RC. Patient-ventilator asynchrony in amyotrophic lateral sclerosis (ALS) patients beginning nocturnal non invasive ventilation (nNIV) for FVC<50% predicted. Am. J. Respir. Crit. Care Med. 183, A5276 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.